Recommendations Regarding Hyperglycaemia, Blood Pressure and Lipid Management in Diabetes Mellitus – Presentation of Key Aspects from the 2019 ESC/EASD Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases-Reference-Cited by-同舟云学术

Recommendations Regarding Hyperglycaemia, Blood Pressure and Lipid Management in Diabetes Mellitus – Presentation of Key Aspects from the 2019 ESC/EASD Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases

Published:2021-01-01 Issue:1 Volume:18 Page:35-40
ISSN:1220-5818
Container-title:Internal Medicine
language:en
Short-container-title:

Author:

Vesa Cosmin Mihai¹,Popa Amorin¹²,Popoviciu Mihaela¹²,Popa Loredana²,Popescu Mircea I.¹²,Sabău Monica¹²,Daina Lucia¹²,Carp Gheorghe¹²

Affiliation:

1. Faculty of Medicine and Pharmacy , University of Oradea , 410073 Oradea , Romania

2. Clinical County Emergency Hospital of Oradea , 410169 Oradea ; Romania

Abstract

Abstract The purpose of our review is to bring to the clinical specialities physicians’ attention the recommendations regarding diabetes mellitus (DM) management presented in the 2019 ESC/EASD Guidelines on diabetes, pre-diabetes and cardiovascular diseases. Key aspects from the guideline regarding blood pressure, lipid and glucose modern management are presented with focus of reducing cardiovascular risk in diabetes mellitus patients. The clinician must not forget that every DM patient is a candidate for a future cardiovascular event and that multifactorial and patient-adapted therapy is the key approach in reducing this risk.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Link

https://www.sciendo.com/pdf/10.2478/inmed-2021-0149

Reference13 articles.

1. 1. Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323. doi:10.1093/eurheartj/ehz486

2. 2. Ryden L, Grant PJ, et.al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34:30353087

3. 3. Piepoli MF, Hoes AW, et.al; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:23152381.

4. 4. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017.

5. 5. Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese. Hypertens Res. 2017 Sep;40(9):795-806. doi: 10.1038/hr.2017.67. Epub 2017 Jul 13. PMID: 28701739.